TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.

Vivek Shinde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.